Functional Imaging with (18)F-FDG PET/CT and Diffusion Weighted Imaging (DWI) in Early Response Evaluation of Combination Therapy of Elotuzumab, Lenalidomide, and Dexamethasone in a Relapsed Multiple Myeloma Patient

Elotuzumab is the first monoclonal antibody approved for the treatment of relapsed-refractory multiple myeloma (MM) in combination with lenalidomide, an immunodulatory drug, and dexamethasone. We report on a multiply pre-treated MM patient with disease progression due to appearance of new focal lesi...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Diagnostics (Basel)
Päätekijät: Sachpekidis, Christos, Dimitrakopoulou-Strauss, Antonia, Delorme, Stefan, Goldschmidt, Hartmut
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: MDPI 2017
Aiheet:
Interesting Images
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5745397/
https://ncbi.nlm.nih.gov/pubmed/29244720
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diagnostics7040061
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia